Capza Expansion and Groupe Caravelle-backed Mayoly Spindler, a firm that manufactures pharmaceutical products, agreed to acquire the consumer healthcare business from Ipsen, a developer of therapies for treatment of endocrine and neurological diseases, for $447m. This is a major step forward in the company’s execution of its strategic roadmap presented in December 2020 towards building a more-focused Ipsen, centring on specialty care.